The purpose of this study is to perform several major preclinical experiments toward use of MEMS devices for cancer therapy. We successfully fabricated during the previous grant period two types of MEMS devices, a solid-state silicon microchip (active device) and a resorbable polymeric microchip (passive device) in which a number of drugs or other chemicals can be stored. We have further shown that both the materials of construction and operation of the device meet the major criteria of being biocompatible. We have also shown that both devices can release single or multiple doses of a chemical substance in vitro and in vivo. Finally, we have demonstrated that a chemotherapeutic agent delivered from each type of device affects growth of a 9L glioma in an experimental rat flank model. Our specific goals are paraphrased as follows: Design for failsafe operation and accuracy of devices. This will ensure complete release of the drug payload within the necessary time frame and provide means to validate that the payload has indeed been released. Demonstrate appropriate pharmacokinetics from implanted microchip devices. We will characterize the drug transport issues both inside and outside the device, including drug transport through the thin fibrous capsule that forms on these devices upon long term implantation. A recent published report shows that the effect of drug transport through the fibrous capsule is not significant. Our proposed research will build a sound scientific basis for the limits of transport through fibrotic tissue surrounding drug delivery devices and we will study the effects of potential additives for their ability to modulate the transport through the capsule. Develop a minimally invasive drug delivery device. We will develop a passive polymeric device capable of implantation through syringe injection. This is expected to provide the largest impact for treatment of brain tumors that are unresectable or otherwise inaccessible conventional therapy. Optimize combination BCNU/IL-2 chemotherapy regimen for 9L glioma model. Demonstrate the ability of both the active and passive MEMS devices to deliver multiple compounds in a specific timed manner. This specifically requires that we: 1) Design and fabricate active and passive MEMS devices to locally release BCNU and IL-2 at specified times. 2) Evaluate these combination devices in an in vivo model to determine bioavailability, interactivity and efficacy of multiple compounds released from these devices.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB006365-10
Application #
8112746
Study Section
Gene and Drug Delivery Systems Study Section (GDD)
Program Officer
Peterson, Karen P
Project Start
1999-09-30
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2013-07-31
Support Year
10
Fiscal Year
2011
Total Cost
$1,116,773
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Xue, Yuan; Xu, Xiaoyang; Zhang, Xue-Qing et al. (2016) Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl Acad Sci U S A 113:5552-7
Chen, Sidi; Xue, Yuan; Wu, Xuebing et al. (2014) Global microRNA depletion suppresses tumor angiogenesis. Genes Dev 28:1054-67
Upadhyay, Urvashi M; Tyler, Betty; Patta, Yoda et al. (2014) Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain. Proc Natl Acad Sci U S A 111:16071-6
Rujitanaroj, Pim-on; Jao, Brian; Yang, Junghoon et al. (2013) Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing. Acta Biomater 9:4513-24
Cohen-Karni, Tzahi; Langer, Robert; Kohane, Daniel S (2012) The smartest materials: the future of nanoelectronics in medicine. ACS Nano 6:6541-5
Stevenson, Cynthia L; Santini Jr, John T; Langer, Robert (2012) Reservoir-based drug delivery systems utilizing microtechnology. Adv Drug Deliv Rev 64:1590-602
Masi, Byron C; Tyler, Betty M; Bow, Hansen et al. (2012) Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model. Biomaterials 33:5768-75
Cohen-Karni, Tzahi; Jeong, Kyung Jae; Tsui, Jonathan H et al. (2012) Nanocomposite gold-silk nanofibers. Nano Lett 12:5403-6
Dvir, Tal; Bauer, Michael; Schroeder, Avi et al. (2011) Nanoparticles targeting the infarcted heart. Nano Lett 11:4411-4
Kaji, Hirokazu; Camci-Unal, Gulden; Langer, Robert et al. (2011) Engineering systems for the generation of patterned co-cultures for controlling cell-cell interactions. Biochim Biophys Acta 1810:239-50

Showing the most recent 10 out of 16 publications